568 related articles for article (PubMed ID: 17611609)
1. Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation.
Sharda S; Phadke SR
J Perinatol; 2007 Sep; 27(9):550-5. PubMed ID: 17611609
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting the decision regarding amniocentesis in women at genetic risk because of age 35 years or older.
Vergani P; Locatelli A; Biffi A; Ciriello E; Zagarella A; Pezzullo JC; Ghidini A
Prenat Diagn; 2002 Sep; 22(9):769-74. PubMed ID: 12224068
[TBL] [Abstract][Full Text] [Related]
3. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
[TBL] [Abstract][Full Text] [Related]
4. Anxiety and prenatal testing: do women with soft ultrasound findings have increased anxiety compared to women with other indications for testing?
Hoskovec J; Mastrobattista JM; Johnston D; Kerrigan A; Robbins-Furman P; Wicklund CA
Prenat Diagn; 2008 Feb; 28(2):135-40. PubMed ID: 18236427
[TBL] [Abstract][Full Text] [Related]
5. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
[TBL] [Abstract][Full Text] [Related]
6. The role of genetic counseling on decisions of pregnant women aged 35 years or over regarding amniocentesis in Turkey.
Ilgin-Ruhi H; Yürür-Kutlay N; Tükün A; Bökesoy I
Eur J Med Genet; 2005; 48(1):13-9. PubMed ID: 15953401
[TBL] [Abstract][Full Text] [Related]
7. Risk factors for procedure-related fetal losses after mid-trimester genetic amniocentesis.
Kong CW; Leung TN; Leung TY; Chan LW; Sahota DS; Fung TY; Lau TK
Prenat Diagn; 2006 Oct; 26(10):925-30. PubMed ID: 16838383
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Nicolaides' risk evaluation for Down's syndrome with a novel software: an analysis of 1,463 cases.
Schmidt P; Staboulidou I; Soergel P; Wüstemann M; Hillemanns P; Scharf A
Arch Gynecol Obstet; 2007 Jun; 275(6):469-74. PubMed ID: 17333228
[TBL] [Abstract][Full Text] [Related]
9. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
[TBL] [Abstract][Full Text] [Related]
10. The association of aneuploidy and unexplained elevated maternal serum alpha-fetoprotein.
Hiett AK; Callaghan CM; Brown HL; Golichowski AM; Heerema NA
J Perinatol; 1998; 18(5):343-6. PubMed ID: 9766408
[TBL] [Abstract][Full Text] [Related]
11. History of miscarriage and increased incidence of fetal aneuploidy in subsequent pregnancy.
Bianco K; Caughey AB; Shaffer BL; Davis R; Norton ME
Obstet Gynecol; 2006 May; 107(5):1098-102. PubMed ID: 16648416
[TBL] [Abstract][Full Text] [Related]
12. The impact of first-trimester screening on AMA patients' uptake of invasive testing.
Wray AM; Ghidini A; Alvis C; Hodor J; Landy HJ; Poggi SH
Prenat Diagn; 2005 May; 25(5):350-3. PubMed ID: 15906421
[TBL] [Abstract][Full Text] [Related]
13. [How to improve the screening and diagnosis of fetal aneuploidy?].
Ville Y
Bull Acad Natl Med; 2005 Nov; 189(8):1773-84; discussion 1784-7. PubMed ID: 16737102
[TBL] [Abstract][Full Text] [Related]
14. Second-trimester minor ultrasound anomalies: impact on the risk of aneuploidy associated with advanced maternal age.
Drugan A; Johnson MP; Reichler A; Hume RF; Itskovicz-Eldor J; Evans MI
Obstet Gynecol; 1996 Aug; 88(2):203-6. PubMed ID: 8692502
[TBL] [Abstract][Full Text] [Related]
15. Assessment of demand for prenatal diagnostic testing using willingness to pay.
Caughey AB; Washington AE; Gildengorin V; Kuppermann M
Obstet Gynecol; 2004 Mar; 103(3):539-45. PubMed ID: 14990419
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound-adjusted risk and spectrum of fetal chromosomal abnormality in women with elevated maternal serum alpha-fetoprotein.
Megerian G; Godmilow L; Donnenfeld AE
Obstet Gynecol; 1995 Jun; 85(6):952-6. PubMed ID: 7539525
[TBL] [Abstract][Full Text] [Related]
17. Pregnant women of 35 years of age or more: maternal serum markers or amniocentesis?
Antsaklis A; Papantoniou N; Mesogitis S; Michalas S; Aravantinos D
J Obstet Gynaecol; 1999 May; 19(3):253-6. PubMed ID: 15512289
[TBL] [Abstract][Full Text] [Related]
18. [Prenatal investigations for Down's syndrome: medical-technical considerations and dilemmas arising from current screening methods].
Grijseels EW; Laudy JA; Galjaard RJ; Wildschut HI
Ned Tijdschr Geneeskd; 2004 Oct; 148(44):2166-71. PubMed ID: 15559409
[TBL] [Abstract][Full Text] [Related]
19. [Fetal malformations and chromosome abnormalities diagnosed at the Center of Prenatal Diagnosis of the University of Aquila in the 1995-1998 triennium].
Carta G; Iovenitti P; D'Alfonso A; Mascaretti G; Moscarini M
Minerva Ginecol; 1999 Oct; 51(10):393-8. PubMed ID: 10638165
[TBL] [Abstract][Full Text] [Related]
20. [Prenatal diagnosis of fetal malformations from the obstetrician's viewpoint].
Winter R
Wien Klin Wochenschr; 1983 Feb; 95(3):67-78. PubMed ID: 6190319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
